FindTrial
Sign In

To explore the core pathogenesis of postoperative recurrence and metastasis of esophageal cancer based on a registry platform

To explore the core pathogenesis of postoperative recurrence and metastasis of esophageal cancer based on a registry platform

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066439
Enrollment
Unknown
Registered
2022-12-06
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Case series:no

Sponsors

Guang 'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Esophageal cancer was confirmed by pathology; 2. R0 resection of esophageal cancer; 3. Surgical methods include endoscopic mucosal and submucosal resection, thoracotomy, thoracoscopic surgery, etc. 4. good compliance with questionnaire survey;

Exclusion criteria

Exclusion criteria: 1. patients with multiple cancers; 2. Complicated with serious primary diseases of the heart, cerebrovascular, liver, kidney, hematopoietic system; 3. the mentally ill and those with intellectual and language disorders; 4. repeat patients; 5. pregnant or lactating women;

Design outcomes

Primary

MeasureTime frame
Disease-free survival time;—

Secondary

MeasureTime frame
The 1 -, 2 -, and 3-year cumulative recurrence and metastasis rates and survival rates;Quality of life and symptoms of esophageal cancer;Physical and chemical examination;Prognostic nutritional index;Body mass index;Inflammatory markers in peripheral blood;—

Countries

China

Contacts

Public ContactJie Li

Guang 'anmen Hospital, China Academy of Chinese Medical Sciences

qfm2020jieli@yeah.net+86 010 88001711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026